Skip to content
OpenCapital
Get started

Clarivate CLVT Life Sciences & Healthcare — Technology Expenses

Similar metrics at other companies

Root, Inc. logo
ROOTTechnology and development
$15.2M+33.3%
Trupanion logo
TRUPOther Segments — Technology and Development Expense
$3.37M+31.1%
SLM logo
SLMReportable Segment — Technology expenses
$21.23M+15.7%
Revvity logo
RVTYLife Sciences — Segment research and development expenses
$31.62M+11.9%
Ziff Davis logo
ZDTechnology & Shopping — Total capital expenditures
$4.54M+25.8%
Robinhood Markets, Inc. logo
HOODTechnology and Development Expense
$241M+12.6%

Other financials

Income statement

See full
Revenue$585.5M-1.4%
Gross profit$393.4M+1.7%
Operating income$30.2M+245%
Net income-$40.2M+61.3%
EPS (diluted)-$0.06+60.0%

Balance sheet

See full
Cash & equivalents$242.2M-31.6%
Total debt$4.4B-5.7%
Total equity$4.8B-4.7%
Total assets$10.9B-4.9%

Cash flow

See full
Operating cash flow$134.7M-21.3%
CapEx$55.8M-8.4%
Free cash flow$78.9M-28.5%

Valuation

See full
Market cap$1.28B-55.2%
Enterprise value$5.45B-24.2%
P/S0.5×-0.6×

Profitability

See full
Gross margin66.5%+0.5pp
Operating margin5%+2.9pp
Net margin-5.7%-2.5pp
FCF margin13.6%-0.4pp

Returns & leverage

See full
Return on equity-2.9%-1.2pp
Debt / equity0.9×0.0×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept clvt:TechnologyExpenses.

The official record: Clarivate’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's life sciences & healthcare — technology expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarivate's life sciences & healthcare — technology expenses?
Clarivate (CLVT) reported life sciences & healthcare — technology expenses of $6.6M in Q1 2026.
How has Clarivate's life sciences & healthcare — technology expenses changed year-over-year?
Clarivate's life sciences & healthcare — technology expenses decreased by 5.7% year-over-year, from $7M to $6.6M.
What is the long-term trend for Clarivate's life sciences & healthcare — technology expenses?
Over 3 years (2022 to 2025), Clarivate's life sciences & healthcare — technology expenses has grown at a 9.8% compound annual growth rate (CAGR), from $21.6M to $28.6M.
What does life sciences & healthcare — technology expenses mean?
This metric tracks the investment in software development, IT infrastructure, and digital platforms required to deliver the segment's workflow solutions. It provides insight into the segment's commitment to technological innovation and the maintenance of its digital product ecosystem.